Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Shelter Pharma Ltd
Your Vote -
Buy
40.00%
Hold
20.00%
Sell
40.00%
40.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Shelter Pharma Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Shelter Pharma - Approved Tuesday, 23Rd September , 2025 As The Cut-Off Date As For The Purpose Of E-Voting And Dividend Enti
-
Shelter Pharma - To Close The Register Of Members Of The Company From Wednesday, 24Th September, 2025 To Tuesday, 30Th Septem
-
Shelter Pharma - The 18Th Annual General Meeting Of The Company Will Be Held On Tuesday, 30Th September, 2025 At 10:00 A.M. A
-
Shelter Pharma - Corporate Action-Board approves Dividend
-
Shelter Pharma - Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On The Tuesday, 02Nd\r\nSeptember, 20
-
Shelter Pharma - Board Meeting Intimation for Intimation Regarding Meeting Of The Board Of Directors Of The Company That Will
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
-
Shelter Pharma has submitted to BSE the Shareholding Pattern for the Period Ended August 05, 2025
-
Shelter Pharma - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Allotment
-
Shelter Pharma - Board Meeting Outcome for Outcome Of Board Meeting Dated 06Th August, 2025 For Allotment Of 88,08,000 Warra
-
Shelter Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Shelter Pharma - Shareholder Meeting / Postal Ballot-Outcome of EGM
-
Shelter Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Shelter Pharma - Intimation Of Shelter Pharma'S Participation In AYUSH India Expo 2025 Under Regulation 30 Of SEBI Listing Re
-
Shelter Pharma - Convening Of 01/2025-26 Extra-Ordinary General Meeting ('EGM') On Wednesday, 23Rd July, 2025 At 10:00 A.M At
-
Shelter Pharma - Fixed Thursday, 17Th July, 2025 As The Record Date For The Purpose Of Determining The Eligibility Of The Mem
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Preferential Issue
-
Shelter Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held Today On Thursday, 26Th June, 2025 And Disclosure Un
-
Shelter Pharma - Board Meeting Intimation for Fund Raising
-
Shelter Pharma - Announcement under Regulation 30 (LODR)-Raising of Funds
-
Shelter Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held Today On Wednesday, 18Th June, 2025 And Disclosure U
-
Shelter Pharma - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To The Securities And Exchange Board Of In
Key fundamentals
Evaluate the intrinsic value of Shelter Pharma Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 43.7647 | 36.3931 | 16.2947 | 8.9366 | 7.1865 |
| Liabilities | 43.7647 | 36.3931 | 16.2947 | 8.9366 | 7.1865 |
| Equity | 11.5598 | 11.5598 | 7.7438 | 0.4839 | 0.4839 |
| Gross Profit | 10.0677 | 8.5714 | 8.0574 | 2.9223 | 0.1801 |
| Net Profit | 7.2374 | 6.2002 | 5.7833 | 1.8569 | 0.0509 |
| Cash From Operating Activities | 5.4822 | -1.8502 | 0.0033 | 0 | 0 |
| NPM(%) | 14.28 | 15.49 | 15.99 | 6.17 | 0.22 |
| Revenue | 50.6602 | 40.0229 | 36.1527 | 30.0554 | 22.4834 |
| Expenses | 40.5925 | 31.4515 | 28.0953 | 27.1331 | 22.3032 |
| ROE(%) | 20.2 | 17.31 | 16.14 | 5.18 | 0.14 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Shelter Pharma Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 809.50 | 0.68 | 73.44 | 26.25 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 118.70 | -4.24 | 393.23 | 95.66 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 22.11 | 1.89 | 0.00 | 198.63 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 860.80 | 0.98 | 0.00 | 90.21 | -604.77 | 0.00 |
Company Info
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
The Company was originally converted from a Partnership Firm "M/s Shelter Pharma" to a Public Limited Company on October 12, 2007 as "Shelter Pharma Limited" under the provisions of the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. The Corporate Identification Number of the Company is U24233GJ2007PLC051956.MAJOR EVENTS AND MILESTONES :2007- Conversion of the Company from Partnership firm named Ms Shelter Pharma to Public Limited Company in the name and style of "Shelter Pharma Limited"2008- Received the license to Manufacture for sale of Ayurvedic / Siddha/ or Unani Drugs2010- Registered the operations in Kuwait2013- Registered the Product Coughnal Cough Syrup in UAE2020- Company got ISO certified under ISO 9001:20152023- Added 182 Products to the Product Portfolio of the Company till 2023.
Read More
Parent Organisation
Shelter Pharma Ltd.
Founded
12/10/2007
Managing Director
Mr.Mustaqim Nisarahmed Sabugar
NSE Symbol
FAQ
The current price of Shelter Pharma Ltd is
The 52-week high for Shelter Pharma Ltd is
The market capitalization of Shelter Pharma Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Shelter Pharma Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Shelter Pharma Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Shelter Pharma Ltd shares.
The CEO of Shelter Pharma Ltd is Mr.Mustaqim Nisarahmed Sabugar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
